| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 01/12/2006 | US20060009651 Benzophenones as inhibitors of reverse transcriptase |
| 01/12/2006 | US20060009528 Cannabinoid receptor ligands |
| 01/12/2006 | US20060009527 Method of treating TRX mediated diseases |
| 01/12/2006 | US20060009526 Method of treating TRX mediated diseases |
| 01/12/2006 | US20060009525 Hydroxamic acids and acyl hydroxamines as NAALADase inhibitors |
| 01/12/2006 | US20060009513 Nebivolol and its metabolites in combination with nitric oxide donors, compositions and methods of use |
| 01/12/2006 | US20060009508 5-alkyl-2-thia-5-azabicyclo[2.2.1]heptan-3-ones or salts thereof which are useful as synthetic intermediates |
| 01/12/2006 | US20060009494 Compositions and methods for use against acne-induced inflammation and dermal matrix-degrading enzymes |
| 01/12/2006 | US20060009482 Screening method for identifying compounds that selectively induce interferon alpha |
| 01/12/2006 | US20060009474 substituted amino pyrimidine derivatives useful in the treatment or prevention of viral infections, in particular against human immunodeficiency virus (HIV), which is the aetiological agent of acquired immune deficiency syndrome (AIDS) in humans |
| 01/12/2006 | US20060009463 N-(3-rifamycinyl)-carbamates, method of preparing them and their use for treating and preventing tuberculosis |
| 01/12/2006 | US20060009438 Administering steroid (such as estrogen) containing hydrophobic substitutions such as adamantane ring; therapy for Alzheimer's, Parkinson's, huntington's disease; multiple sclerosis; amyotrophic lateral sclerosis; strokes; antiischemic agents |
| 01/12/2006 | US20060009409 Double-stranded oligonucleotides |
| 01/12/2006 | US20060009402 Engineered RNA precursors encoded in plasmids and/or other vectors; simple, low cost technique utilizing DNA molecule production; host cells, transgenes |
| 01/12/2006 | US20060009383 Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same |
| 01/12/2006 | US20060008797 Peptide that that binds to microglial receptors; may be conjugated to a carrier molecule that increases transport across the blood-brain barrier; treating neurological effects of cerebral ischemia or cerebral inflammation |
| 01/12/2006 | US20060008476 Adjuvanted antigenic meningococcal compositions |
| 01/12/2006 | US20060008474 Polypeptides containing polymorphisms of the repeated regions of pertactin in Bordetella pertussis, Bordetella parapertussis, and Bordetella bronchiseptica, their use in diagnostics, and in immunogenic compositions |
| 01/12/2006 | US20060008471 Organ, tissue and cell-specific immuno-therapeutic for chronic viral infections and inflammatory, degenerative and proliferative diseases, in particular of the liver, and for cancer, based on a recombinant parapox virus |
| 01/12/2006 | US20060008467 Human immunodeficiency virus vaccine |
| 01/12/2006 | US20060008460 Inhibits B-cell activation by binding to protein receptor on helper T-cell membrane; treatment of allergy or autoimmune disease |
| 01/12/2006 | US20060008459 Combination therapy of respiratory diseases using antibodies |
| 01/12/2006 | DE4216644B4 Liposomen enthaltende Arzneimittel Liposomes containing drugs |
| 01/12/2006 | DE202005017669U1 Antimicrobial agent, useful to treat respiratory tract related microorganisms or infectious diseases in nose-, throat- or paranasal sinuses, comprises plant drug or ethanolic/aqueous extracts (e.g. Rumex acetosa L) |
| 01/12/2006 | DE19961182B4 Galactomannan-Oligosaccharide und Verfahren zu deren Herstellung sowie deren Verwendung Galactomannan oligosaccharides and processes for their preparation and their use |
| 01/12/2006 | CA2628005A1 Oral antimicrobial pharmaceutical compositions |
| 01/12/2006 | CA2572310A1 Sphingolipid-derived pharmaceutical compositions |
| 01/12/2006 | CA2571440A1 Use of steroid-derived pharmaceutical compositions for treating disorders relating to pathological processes in lipid rafts |
| 01/12/2006 | CA2570533A1 Substituted hydroxyacetophenon derivatives |
| 01/12/2006 | CA2570245A1 Compositions and methods for treating pathological infections |
| 01/12/2006 | CA2569824A1 Phthalazine derivatives as parp inhibitors |
| 01/12/2006 | CA2569681A1 Method for increasing the susceptibility of peptide deformylase inhibitors by using efflux pump inhibitors |
| 01/12/2006 | CA2569530A1 Thienopyrazole derivative having pde 7 inhibitory activity |
| 01/11/2006 | EP1615032A1 Method of detecting onset risk of encephalitis or encephalopathy |
| 01/11/2006 | EP1614695A1 Polypeptide |
| 01/11/2006 | EP1614423A2 Attenuated pestiviruses |
| 01/11/2006 | EP1614414A2 Compositions comprising a copper compound for treatment of mammalian diseases |
| 01/11/2006 | EP1613736A2 Inhibition of viral pathogenesis |
| 01/11/2006 | EP1613650A2 Severe acute respiratory syndrome (sars) causing coronavirus |
| 01/11/2006 | EP1613641A2 Cholesterol-containing compounds and their use as immunogens against borrelia burgdorferi |
| 01/11/2006 | EP1613634A1 Indole acetamides as inhibitors of the hepatitis c virus ns5b polymerase |
| 01/11/2006 | EP1613628A2 Reversible inhibitors of s-adenosyl-l-homocysteine hydrolase and uses thereof |
| 01/11/2006 | EP1613554A1 Functionalized carbon nanotubes, a process for preparing the same and their use in medicinal chemistry |
| 01/11/2006 | EP1613397A2 Use of bacteriocin for the amelioration of digestive functionality |
| 01/11/2006 | EP1613345A2 Compositions and methods involving respiratory syncytial virus subgroup b strain 9320 |
| 01/11/2006 | EP1613342A1 Interferon beta in severe acute respiratory syndrome (sars) |
| 01/11/2006 | EP1613340A2 Treatment of aspergillus infections with thymosin alpha 1 |
| 01/11/2006 | EP1613339A2 Anti-fungal peptidomimetics |
| 01/11/2006 | EP1613331A1 Compositions containing lactulose for treating rotavirus infections |
| 01/11/2006 | EP1613316A1 Compositions comprising macrolide t-cell immunomodulators or immunosuppressants in combination with antibacterials |
| 01/11/2006 | EP1613305A1 Crystalline n-formyl hydroxylamine compounds |
| 01/11/2006 | EP1613288A1 Solid pharmaceutical compositions comprising a s1p receptor agonist and a sugar alcohol |
| 01/11/2006 | EP1613273A2 Recombinant il-9 antibodies and uses thereof |
| 01/11/2006 | EP1613262A2 In vitro assays for inhibitors of hiv capsid conformational changes and for hiv capsid formation |
| 01/11/2006 | EP1421082B1 piperidinyl-morpholinyl derivatives as modulators of chemokine receptor activity |
| 01/11/2006 | EP1414481B1 Use of cetrorelix for the treatment of jacob-creutzfeldt-disease |
| 01/11/2006 | EP1407033B1 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (mva) |
| 01/11/2006 | EP1399130A4 Emulsion and dispersion formulations and method |
| 01/11/2006 | EP1392830B1 Interleukin-18 mutants, their production and use |
| 01/11/2006 | EP1366036B1 Compounds having activity as inhibitors of cytochrome p450rai |
| 01/11/2006 | EP1338596B1 processes for the preparation of carbapenem-type antibacterial agents |
| 01/11/2006 | EP1320375B1 Inhibition of systemic infections in humans and vertebrates by dietary fibers |
| 01/11/2006 | EP1296670B1 Therapeutic combinations of fatty acids |
| 01/11/2006 | EP1294924B1 Competitive assay for identifying allosteric inhibitors |
| 01/11/2006 | EP1256342B1 Hypoglycemics comprising organic zinc (ii) complexes |
| 01/11/2006 | EP1240328B1 Antigenic protein lppq of mycoplasma mycoides subsp. mycoides sc., its preparation and use |
| 01/11/2006 | EP1156817A4 Controlling protein levels in eucaryotic organisms |
| 01/11/2006 | EP1142573B1 Pharmaceutical compositions comprising faropenem sodium and a diamineacetate compound for improving gastrointestinal absorption |
| 01/11/2006 | EP1131315B1 Polyhydroxylated heterocyclic derivatives as anti-coagulants |
| 01/11/2006 | EP1124839B1 Nucleosides with anti-hepatitis b virus activity |
| 01/11/2006 | EP1119630B1 Nucleic acid constructs for genetic immunisation |
| 01/11/2006 | EP1113816B1 Influenza virus vaccine composition |
| 01/11/2006 | EP1100537B1 Multivalent human-bovine rotavirus vaccine |
| 01/11/2006 | EP1073749B1 Enhancing immune responses to genetic immunization by using a chemokine |
| 01/11/2006 | EP1047422B1 Use of histamine for elevating blood histamine levels |
| 01/11/2006 | EP0941064B1 PHARMACEUTICAL PREPARATIONS FOR THE CONTROLLED RELEASE OF beta -LACTAM ANTIBIOTICS |
| 01/11/2006 | EP0831912B1 Improved formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents |
| 01/11/2006 | EP0821692B1 Immunopotentiating inosine monophosphate 5'-nucleotidase resistant derivatives and uses thereof |
| 01/11/2006 | EP0771352B1 Nontypable haemophilus influenzae lkp tip adhesin protein and nucleic acid |
| 01/11/2006 | EP0728209B1 Endothelin-converting enzyme |
| 01/11/2006 | CN1720326A Method of strengthening foreign epitope presentation by MHC class I by inhibiting TAP activity |
| 01/11/2006 | CN1720257A Methods of down regulating target gene expression in vivo by introduction of interfering RNA |
| 01/11/2006 | CN1718245A Nucleic acid vaccine, and its application |
| 01/11/2006 | CN1718243A Immunological adjuvant, and its application in preparing vaccine and medicine for anti-virus |
| 01/11/2006 | CN1718242A Recombination vaccine of dog-2 type adenovirus for lyssic virus gluco-/nucleo-structured protein |
| 01/11/2006 | CN1718237A Traditional Chinese medicine composition for treating colpitis and cervicitis, prepn. method and quality standard therefor |
| 01/11/2006 | CN1718236A Epidemic prevention method for domestic birds using traditional Chinese herbs and formula thereof |
| 01/11/2006 | CN1718232A Compound traditional Chinese medicine for treating acute gastroenteritis and anti-influenzavirus, and its prepn. method |
| 01/11/2006 | CN1718226A Medicine composition for treating leuconychia, and its prepn. method |
| 01/11/2006 | CN1718222A Anti-inflammation buccal tablet |
| 01/11/2006 | CN1718202A Prescription of Chinese herb medicine for nourishing-heart replenishing-qi, and Chinese patent drug or Chinese herb medicine drink therefrom |
| 01/11/2006 | CN1718198A Pharmaceutical composition, prepn. method and medical use thereof |
| 01/11/2006 | CN1718197A Pharmaceutical composition contg .bifidobacterium, prepn. method and medical use thereof |
| 01/11/2006 | CN1718196A Pharmaceutical composition contg. lactobacillus, prepn. method and medical use thereof |
| 01/11/2006 | CN1718184A Neo-garcinolic acid composition having anti-neoplastic activity, prepn. method and use thereof |
| 01/11/2006 | CN1718182A Use of vegetable flavonoid |
| 01/11/2006 | CN1235914C Polysaccharides with antithrombotic activity comprising at least a covalent bono with biotin or a biotin derivative |
| 01/11/2006 | CN1235911C Multiple cytokine-antibody complexes |
| 01/11/2006 | CN1235909C Recombination human interferon alpha 8 polypeptide coding cDNA sequence, preparation method and application |
| 01/11/2006 | CN1235900C Thioether substituted imidazoquinolines |